Potential effects of allyl isothiocyanate on inhibiting cellular proliferation and inducing apoptotic pathway in human cisplatin-resistant oral cancer cells
Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential...
Saved in:
| Published in | Journal of the Formosan Medical Association Vol. 120; no. 1; pp. 515 - 523 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
Elsevier B.V
01.01.2021
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential as a natural dietary chemopreventive compound against a variety of cancers, but the effect of AITC on cisplatin-resistant cancer cells is still little-known.
Human CAL27-cisplatin-resistant oral cancer cells (CAR cells) were examined to investigate the antitumor properties of AITC. 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, IncuCyte™ S3 cell proliferation assay, 4′,6-diamidino-2-phenylindole (DAPI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as well as Western blot analysis were deployed.
AITC decreased CAR cell viability, induced cell death of CAR cells and inhibited the confluences of cultured CAR cells. When CAR cells were treated with AITC, activation of caspase-3 and caspase-9 by AITC was observed and could be reversed by Z-VAD-fmk (pan-caspase inhibitor). Furthermore, the protein expressions of phosphorylated protein kinase B (p-AKT) and phosphorylated mammalian target of rapamycin (p-mTOR) were suppressed in AITC-treated CAR cells, whereas protein expressions of Bax, cytochrome c, Apaf-1, cleaved caspase-3, and cleaved caspase-9 were upregulated in AITC-treated CAR cells.
AITC can inhibit Akt/mTOR proliferation signaling and promote mitochondria-dependent apoptotic pathway through AITC-enhanced activities of caspase-3 and caspase-9 in CAR cells. |
|---|---|
| AbstractList | Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential as a natural dietary chemopreventive compound against a variety of cancers, but the effect of AITC on cisplatin-resistant cancer cells is still little-known.
Human CAL27-cisplatin-resistant oral cancer cells (CAR cells) were examined to investigate the antitumor properties of AITC. 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, IncuCyte™ S3 cell proliferation assay, 4′,6-diamidino-2-phenylindole (DAPI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as well as Western blot analysis were deployed.
AITC decreased CAR cell viability, induced cell death of CAR cells and inhibited the confluences of cultured CAR cells. When CAR cells were treated with AITC, activation of caspase-3 and caspase-9 by AITC was observed and could be reversed by Z-VAD-fmk (pan-caspase inhibitor). Furthermore, the protein expressions of phosphorylated protein kinase B (p-AKT) and phosphorylated mammalian target of rapamycin (p-mTOR) were suppressed in AITC-treated CAR cells, whereas protein expressions of Bax, cytochrome c, Apaf-1, cleaved caspase-3, and cleaved caspase-9 were upregulated in AITC-treated CAR cells.
AITC can inhibit Akt/mTOR proliferation signaling and promote mitochondria-dependent apoptotic pathway through AITC-enhanced activities of caspase-3 and caspase-9 in CAR cells. Background/purpose: Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential as a natural dietary chemopreventive compound against a variety of cancers, but the effect of AITC on cisplatin-resistant cancer cells is still little-known. Methods: Human CAL27-cisplatin-resistant oral cancer cells (CAR cells) were examined to investigate the antitumor properties of AITC. 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, IncuCyte™ S3 cell proliferation assay, 4′,6-diamidino-2-phenylindole (DAPI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as well as Western blot analysis were deployed. Results: AITC decreased CAR cell viability, induced cell death of CAR cells and inhibited the confluences of cultured CAR cells. When CAR cells were treated with AITC, activation of caspase-3 and caspase-9 by AITC was observed and could be reversed by Z-VAD-fmk (pan-caspase inhibitor). Furthermore, the protein expressions of phosphorylated protein kinase B (p-AKT) and phosphorylated mammalian target of rapamycin (p-mTOR) were suppressed in AITC-treated CAR cells, whereas protein expressions of Bax, cytochrome c, Apaf-1, cleaved caspase-3, and cleaved caspase-9 were upregulated in AITC-treated CAR cells. Conclusion: AITC can inhibit Akt/mTOR proliferation signaling and promote mitochondria-dependent apoptotic pathway through AITC-enhanced activities of caspase-3 and caspase-9 in CAR cells. Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential as a natural dietary chemopreventive compound against a variety of cancers, but the effect of AITC on cisplatin-resistant cancer cells is still little-known.BACKGROUND/PURPOSECisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl isothiocyanate (AITC), known as mustard oil, is a plant-derived compound abundant in cruciferous vegetables. It is reported to have anti-cancer potential as a natural dietary chemopreventive compound against a variety of cancers, but the effect of AITC on cisplatin-resistant cancer cells is still little-known.Human CAL27-cisplatin-resistant oral cancer cells (CAR cells) were examined to investigate the antitumor properties of AITC. 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, IncuCyte™ S3 cell proliferation assay, 4',6-diamidino-2-phenylindole (DAPI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as well as Western blot analysis were deployed.METHODSHuman CAL27-cisplatin-resistant oral cancer cells (CAR cells) were examined to investigate the antitumor properties of AITC. 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay, IncuCyte™ S3 cell proliferation assay, 4',6-diamidino-2-phenylindole (DAPI) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining as well as Western blot analysis were deployed.AITC decreased CAR cell viability, induced cell death of CAR cells and inhibited the confluences of cultured CAR cells. When CAR cells were treated with AITC, activation of caspase-3 and caspase-9 by AITC was observed and could be reversed by Z-VAD-fmk (pan-caspase inhibitor). Furthermore, the protein expressions of phosphorylated protein kinase B (p-AKT) and phosphorylated mammalian target of rapamycin (p-mTOR) were suppressed in AITC-treated CAR cells, whereas protein expressions of Bax, cytochrome c, Apaf-1, cleaved caspase-3, and cleaved caspase-9 were upregulated in AITC-treated CAR cells.RESULTSAITC decreased CAR cell viability, induced cell death of CAR cells and inhibited the confluences of cultured CAR cells. When CAR cells were treated with AITC, activation of caspase-3 and caspase-9 by AITC was observed and could be reversed by Z-VAD-fmk (pan-caspase inhibitor). Furthermore, the protein expressions of phosphorylated protein kinase B (p-AKT) and phosphorylated mammalian target of rapamycin (p-mTOR) were suppressed in AITC-treated CAR cells, whereas protein expressions of Bax, cytochrome c, Apaf-1, cleaved caspase-3, and cleaved caspase-9 were upregulated in AITC-treated CAR cells.AITC can inhibit Akt/mTOR proliferation signaling and promote mitochondria-dependent apoptotic pathway through AITC-enhanced activities of caspase-3 and caspase-9 in CAR cells.CONCLUSIONAITC can inhibit Akt/mTOR proliferation signaling and promote mitochondria-dependent apoptotic pathway through AITC-enhanced activities of caspase-3 and caspase-9 in CAR cells. |
| Author | Hsu, Yuan-man Bau, Da-tian Yang, Jai-sing Tsai, Fuu-jen Chiang, Shang-lun Chang, Pei-ying Tu, Ming-gene |
| Author_xml | – sequence: 1 givenname: Pei-ying surname: Chang fullname: Chang, Pei-ying organization: Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan – sequence: 2 givenname: Fuu-jen surname: Tsai fullname: Tsai, Fuu-jen organization: School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan – sequence: 3 givenname: Da-tian surname: Bau fullname: Bau, Da-tian organization: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan – sequence: 4 givenname: Yuan-man surname: Hsu fullname: Hsu, Yuan-man organization: Department of Biological Science and Technology, China Medical University, Taichung, Taiwan – sequence: 5 givenname: Jai-sing surname: Yang fullname: Yang, Jai-sing organization: Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan – sequence: 6 givenname: Ming-gene surname: Tu fullname: Tu, Ming-gene email: mgtu@mail.cmu.edu.tw organization: School of Dentistry, China Medical University, Taichung, Taiwan – sequence: 7 givenname: Shang-lun surname: Chiang fullname: Chiang, Shang-lun email: chimpanzee99999@gmail.com organization: Environment-Omics-Disease Research Center, China Medical University Hospital, Taichung, Taiwan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32624316$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks1uEzEUhUeoiKaFF2CBvGQzwfZ4nBnEBlX8VKoEC1hbd_zT3ODYwfaA8i48LE5SuuiirCzZ5zu2zz0XzVmIwTbNS0aXjDL5ZrPcuC0sOeV0SeWS8v5Js2DDSrZ04OysWdCRj62UQp43FzlvKBVyHOWz5rzjkouOyUXz52ssNhQET6xzVpdMoiPg_d4TzLGsMeo9BCiWxEAwrHHCguGWaOv97CGRXYoenU1QsCogmKoysz5oYBd3JRbUZAdl_Rv29Yis5y0EojHvfEVCm2zGXCAUElN9hYagbTra5-fNUwc-2xd362Xz_eOHb1ef25svn66v3t-0umer0hqmHddyZYwcBilgJTo7UGq0E3zsRed6Iwyl3cQlCMMMG_uhd4aLHqTuaxCXzfXJ10TYqF3CLaS9ioDquBHTrYJUv-GtcsCsmKYOJtBiMKtpGgRwO_AJ6NiNrHq9PnnVXH7ONhe1xXz4DQQb56y44FRyPlJepa_upPO0teb-4n_TqQJ-EugUc07W3UsYVYcKqI06VEAdKqCoVLUCFRoeQBrLcTglAfrH0Xcn1Nawf6FNKmu0dR4GU61GTQMfx98-wLXHgBr8D7v_H_wXenrjrg |
| CitedBy_id | crossref_primary_10_1016_j_sjbs_2022_02_012 crossref_primary_10_26900_hsq_2366 crossref_primary_10_52679_tabcj_2023_0002 crossref_primary_10_1016_j_ejphar_2023_176016 crossref_primary_10_1016_j_oraloncology_2022_106060 crossref_primary_10_1007_s00044_024_03326_9 crossref_primary_10_1007_s00418_023_02255_9 crossref_primary_10_3390_molecules27134106 crossref_primary_10_3390_bioengineering9090470 crossref_primary_10_3390_pharmaceutics14010144 crossref_primary_10_1016_j_ijpharm_2024_124123 crossref_primary_10_3390_molecules27186008 crossref_primary_10_1002_med_21969 crossref_primary_10_1002_ptr_8228 crossref_primary_10_1016_j_phrs_2024_107107 crossref_primary_10_1021_acs_jmedchem_2c01406 crossref_primary_10_1177_09731296231158699 crossref_primary_10_1016_j_gene_2022_146333 crossref_primary_10_3390_biomedicines11102669 crossref_primary_10_1080_14786419_2022_2098958 crossref_primary_10_1146_annurev_food_052720_010127 crossref_primary_10_3390_ijms231910996 crossref_primary_10_3390_molecules26113155 crossref_primary_10_1007_s12668_023_01233_8 crossref_primary_10_1002_fsn3_4296 crossref_primary_10_1007_s11010_023_04697_0 crossref_primary_10_3390_ijms231810411 crossref_primary_10_1002_ptr_7048 crossref_primary_10_1002_ptr_8419 crossref_primary_10_1093_fqsafe_fyad041 crossref_primary_10_3390_foods12122317 |
| Cites_doi | 10.1021/ar300020b 10.1002/mnfr.201000005 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q 10.1016/j.jff.2018.11.040 10.1111/jfbc.12902 10.1051/bmdcn/2017070205 10.1002/mnfr.200900323 10.1016/j.mrfmmm.2014.11.004 10.1158/1078-0432.CCR-03-1077 10.18632/oncotarget.3026 10.1080/01635589209514201 10.1016/j.phrs.2016.01.001 10.1080/09540105.2019.1660623 10.1016/bs.afnr.2019.02.008 10.3390/cancers11070949 10.1111/j.1476-5829.2007.00142.x 10.3892/ijo.2013.2050 10.1021/tx100248s 10.1080/01635581.2017.1320415 10.1002/mnfr.200900265 10.1177/0022034519894963 10.1016/j.ejphar.2014.07.025 10.1080/09540105.2020.1713055 10.1016/j.semcancer.2019.12.008 10.1177/153537020623100408 10.3892/ijo.2012.1579 10.3390/ijms20030755 10.1002/cncr.26446 10.1007/s11010-017-3091-0 10.1111/jop.12440 10.1016/j.critrevonc.2013.12.012 10.1038/onc.2011.384 10.1124/jpet.109.165415 10.1016/j.canlet.2017.11.002 |
| ContentType | Journal Article |
| Copyright | 2020 Formosan Medical Association Copyright © 2020 Formosan Medical Association. Published by Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2020 Formosan Medical Association – notice: Copyright © 2020 Formosan Medical Association. Published by Elsevier B.V. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
| DOI | 10.1016/j.jfma.2020.06.025 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1876-0821 |
| EndPage | 523 |
| ExternalDocumentID | oai_doaj_org_article_fa1e4bb3abac48d7bb84a2e82ba09391 32624316 10_1016_j_jfma_2020_06_025 S0929664620302850 |
| Genre | Journal Article |
| GroupedDBID | --- --K .1- .55 .FO .~1 0R~ 188 1B1 1P~ 1~. 1~5 2UF 2WC 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 8RM AABNK AAEDW AAIKJ AALRI AAQFI AAWTL AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABWVN ABXDB ACGFO ACRPL ACVFH ADCNI ADMUD ADNMO ADVLN AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AGYEJ AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ CS3 DU5 EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU GBLVA GROUPED_DOAJ GX1 HVGLF HZ~ IHE IPNFZ J1W M41 MO0 N9A O-L O9- OK1 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SSZ TR2 UZ5 X7M Z5R ZXP 0SF 6I. AACTN AAFTH AFCTW AHPSJ AINHJ CEFSP CNMHZ LCYCR NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c517t-d1cf2c67dd68864a743e800dcf429543f5d4d003b26a4d1d19585fd245a6c5243 |
| IEDL.DBID | DOA |
| ISSN | 0929-6646 |
| IngestDate | Wed Aug 27 01:28:58 EDT 2025 Thu Jul 10 23:29:09 EDT 2025 Thu Apr 03 07:00:42 EDT 2025 Thu Apr 24 22:58:33 EDT 2025 Tue Jul 01 03:33:52 EDT 2025 Fri Feb 23 02:46:14 EST 2024 Tue Aug 26 20:29:56 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | OSCC AITC Cisplatin resistance CAR cells Apoptosis |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2020 Formosan Medical Association. Published by Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c517t-d1cf2c67dd68864a743e800dcf429543f5d4d003b26a4d1d19585fd245a6c5243 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/fa1e4bb3abac48d7bb84a2e82ba09391 |
| PMID | 32624316 |
| PQID | 2420622902 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_fa1e4bb3abac48d7bb84a2e82ba09391 proquest_miscellaneous_2420622902 pubmed_primary_32624316 crossref_primary_10_1016_j_jfma_2020_06_025 crossref_citationtrail_10_1016_j_jfma_2020_06_025 elsevier_sciencedirect_doi_10_1016_j_jfma_2020_06_025 elsevier_clinicalkey_doi_10_1016_j_jfma_2020_06_025 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | January 2021 2021-01-00 2021-Jan 20210101 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: January 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore |
| PublicationTitle | Journal of the Formosan Medical Association |
| PublicationTitleAlternate | J Formos Med Assoc |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Lee, Wang, Wu, Lin, Tsai, Yang (bib13) 2020; 31 Tafrihi, Nakhaei Sistani (bib10) 2017; 69 Hwang, Lee (bib18) 2006; 231 Lu, Yang, Huang, Hsia, Chou, Kuo (bib31) 2010; 54 Ghantous, Abu-Elnaaj (bib3) 2017; 156 Barabas, Milner, Lurie, Adin (bib7) 2008; 6 (bib16) 2004 Chen, Lu, Chiang, Chiu, Yang, Lee (bib26) 2018; 16 Chiang, Yang, Ma, Yang, Huang, Hsia (bib30) 2011; 24 Khan, Blanco-Codesido, Molife (bib39) 2014; 90 Lee, Wang, Wu, Tsai, Tsai, Chung (bib12) 2019; 30 Zhang (bib15) 2010; 54 Du, Nair, Jamieson, Liu, Bi (bib1) 2020; 99 Ghoneum, Said (bib35) 2019; 11 Qin, Li, Xue (bib19) 2018; 15 Block, Patterson, Subar (bib8) 1992; 18 Chikara, Nagaprashantha, Singhal, Horne, Awasthi, Singhal (bib9) 2018; 413 Chang, Peng, Lee, Lu, Tsai, Shieh (bib25) 2013; 43 Tsai, Yang, Peng, Lu, Chiang, Chung (bib27) 2012; 41 Martins, de Sousa, Dos Santos, Woo, Gallottini (bib37) 2016; 45 Savio, da Silva, Salvadori (bib20) 2015; 771 Galluzzi, Senovilla, Vitale, Michels, Martins, Kepp (bib4) 2012; 31 Argiris, Brockstein, Haraf, Stenson, Mittal, Kies (bib22) 2004; 10 Amable (bib5) 2016; 106 Andon, Fadeel (bib38) 2013; 46 Lin, Chen, Tsai, Tsai, Huang, Tang (bib14) 2019; 43 Slaughter, Southwick, Smejkal (bib24) 1953; 6 Lee, Lin, Lu, Kuo, Tsao, Juan (bib29) 2017; 7 Rajakumar, Pugalendhi, Thilagavathi, Ananthakrishnan, Gunasekaran (bib17) 2018; 437 Tripathi, Hussein, Anupalli, Barnett, Bachaboina, Scalici (bib21) 2015; 6 Tewari, Patni, Bishayee, Sah, Bishayee (bib34) 2019 Huang, Chiu, Fan, Lu, Yeh, Li (bib32) 2010; 54 Lee, Chen, Wang, Fong, Tsai, Tsai (bib11) 2019; 52 Tian, Li, Zhang (bib36) 2019; 20 bib2 Yang, Hour, Huang, Lin, Kuo, Chung (bib28) 2010; 334 Prieto, Lopez, Simal-Gandara (bib33) 2019; 90 Azad, Bairati, Samson, Cheng, Cheng, Mirshams (bib23) 2012; 118 Dasari, Tchounwou (bib6) 2014; 740 Ling, Westover, Cao, Cao, He, Kim (bib40) 2015; 5 Lee (10.1016/j.jfma.2020.06.025_bib11) 2019; 52 Hwang (10.1016/j.jfma.2020.06.025_bib18) 2006; 231 Huang (10.1016/j.jfma.2020.06.025_bib32) 2010; 54 Prieto (10.1016/j.jfma.2020.06.025_bib33) 2019; 90 Lu (10.1016/j.jfma.2020.06.025_bib31) 2010; 54 Chen (10.1016/j.jfma.2020.06.025_bib26) 2018; 16 Tian (10.1016/j.jfma.2020.06.025_bib36) 2019; 20 Martins (10.1016/j.jfma.2020.06.025_bib37) 2016; 45 Amable (10.1016/j.jfma.2020.06.025_bib5) 2016; 106 Chiang (10.1016/j.jfma.2020.06.025_bib30) 2011; 24 Khan (10.1016/j.jfma.2020.06.025_bib39) 2014; 90 Azad (10.1016/j.jfma.2020.06.025_bib23) 2012; 118 Chang (10.1016/j.jfma.2020.06.025_bib25) 2013; 43 Tewari (10.1016/j.jfma.2020.06.025_bib34) 2019 Tsai (10.1016/j.jfma.2020.06.025_bib27) 2012; 41 Dasari (10.1016/j.jfma.2020.06.025_bib6) 2014; 740 Zhang (10.1016/j.jfma.2020.06.025_bib15) 2010; 54 Tripathi (10.1016/j.jfma.2020.06.025_bib21) 2015; 6 Argiris (10.1016/j.jfma.2020.06.025_bib22) 2004; 10 Slaughter (10.1016/j.jfma.2020.06.025_bib24) 1953; 6 Barabas (10.1016/j.jfma.2020.06.025_bib7) 2008; 6 Qin (10.1016/j.jfma.2020.06.025_bib19) 2018; 15 Ghantous (10.1016/j.jfma.2020.06.025_bib3) 2017; 156 Lee (10.1016/j.jfma.2020.06.025_bib13) 2020; 31 Chikara (10.1016/j.jfma.2020.06.025_bib9) 2018; 413 Ghoneum (10.1016/j.jfma.2020.06.025_bib35) 2019; 11 Block (10.1016/j.jfma.2020.06.025_bib8) 1992; 18 Du (10.1016/j.jfma.2020.06.025_bib1) 2020; 99 Lee (10.1016/j.jfma.2020.06.025_bib29) 2017; 7 Savio (10.1016/j.jfma.2020.06.025_bib20) 2015; 771 Ling (10.1016/j.jfma.2020.06.025_bib40) 2015; 5 Rajakumar (10.1016/j.jfma.2020.06.025_bib17) 2018; 437 Lin (10.1016/j.jfma.2020.06.025_bib14) 2019; 43 (10.1016/j.jfma.2020.06.025_bib16) 2004 Andon (10.1016/j.jfma.2020.06.025_bib38) 2013; 46 Lee (10.1016/j.jfma.2020.06.025_bib12) 2019; 30 Galluzzi (10.1016/j.jfma.2020.06.025_bib4) 2012; 31 Tafrihi (10.1016/j.jfma.2020.06.025_bib10) 2017; 69 Yang (10.1016/j.jfma.2020.06.025_bib28) 2010; 334 |
| References_xml | – volume: 54 start-page: 1585 year: 2010 end-page: 1595 ident: bib32 article-title: Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells publication-title: Mol Nutr Food Res – volume: 6 start-page: 5237 year: 2015 end-page: 5252 ident: bib21 article-title: Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation publication-title: Oncotarget – volume: 43 year: 2019 ident: bib14 article-title: Casticin inhibits human prostate cancer DU 145 cell migration and invasion via Ras/Akt/NF-kappaB signaling pathways publication-title: J Food Biochem – volume: 31 start-page: 1869 year: 2012 end-page: 1883 ident: bib4 article-title: Molecular mechanisms of cisplatin resistance publication-title: Oncogene – volume: 740 start-page: 364 year: 2014 end-page: 378 ident: bib6 article-title: Cisplatin in cancer therapy: molecular mechanisms of action publication-title: Eur J Pharmacol – volume: 771 start-page: 29 year: 2015 end-page: 35 ident: bib20 article-title: Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil) publication-title: Mutat Res – volume: 24 start-page: 20 year: 2011 end-page: 29 ident: bib30 article-title: Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways publication-title: Chem Res Toxicol – volume: 413 start-page: 122 year: 2018 end-page: 134 ident: bib9 article-title: Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment publication-title: Canc Lett – volume: 7 start-page: 31 year: 2017 end-page: 42 ident: bib29 article-title: YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells publication-title: Biomedicine – volume: 54 start-page: 967 year: 2010 end-page: 976 ident: bib31 article-title: Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells publication-title: Mol Nutr Food Res – volume: 6 start-page: 963 year: 1953 end-page: 968 ident: bib24 article-title: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin publication-title: Cancer – volume: 90 start-page: 305 year: 2019 end-page: 350 ident: bib33 article-title: Glucosinolates: molecular structure, breakdown, genetic, bioavailability, properties and healthy and adverse effects publication-title: Adv Food Nutr Res – volume: 20 start-page: 755 year: 2019 ident: bib36 article-title: mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy publication-title: Int J Mol Sci – volume: 99 start-page: 143 year: 2020 end-page: 151 ident: bib1 article-title: Incidence trends of lip, oral cavity, and pharyngeal cancers. Global burden of disease 1990-2017 publication-title: J Dent Res – volume: 46 start-page: 733 year: 2013 end-page: 742 ident: bib38 article-title: Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials publication-title: Acc Chem Res – volume: 11 start-page: 949 year: 2019 ident: bib35 article-title: PI3K-AKT-mTOR and NFkappaB pathways in ovarian cancer: implications for targeted therapeutics publication-title: Cancers – volume: 6 start-page: 1 year: 2008 end-page: 18 ident: bib7 article-title: Cisplatin: a review of toxicities and therapeutic applications publication-title: Vet Comp Oncol – volume: 231 start-page: 421 year: 2006 end-page: 430 ident: bib18 article-title: Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells publication-title: Exp Biol Med – volume: 334 start-page: 477 year: 2010 end-page: 488 ident: bib28 article-title: MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells publication-title: J Pharmacol Exp Therapeut – volume: 90 start-page: 200 year: 2014 end-page: 219 ident: bib39 article-title: Cancer therapeutics: targeting the apoptotic pathway publication-title: Crit Rev Oncol Hematol – volume: 5 start-page: 2516 year: 2015 end-page: 2530 ident: bib40 article-title: Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo publication-title: Am J Cancer Res – year: 2019 ident: bib34 article-title: Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy publication-title: Semin Canc Biol – volume: 45 start-page: 746 year: 2016 end-page: 752 ident: bib37 article-title: PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis publication-title: J Oral Pathol Med – volume: 15 start-page: 8756 year: 2018 end-page: 8760 ident: bib19 article-title: Effect of allyl isothiocyanate on the viability and apoptosis of the human cervical cancer HeLa cell line in vitro publication-title: Oncol Lett – volume: 10 start-page: 1956 year: 2004 end-page: 1962 ident: bib22 article-title: Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy publication-title: Clin Canc Res – volume: 54 start-page: 127 year: 2010 end-page: 135 ident: bib15 article-title: Allyl isothiocyanate as a cancer chemopreventive phytochemical publication-title: Mol Nutr Food Res – volume: 41 start-page: 1431 year: 2012 end-page: 1442 ident: bib27 article-title: Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells publication-title: Int J Oncol – volume: 18 start-page: 1 year: 1992 end-page: 29 ident: bib8 article-title: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence publication-title: Nutr Canc – volume: 43 start-page: 1141 year: 2013 end-page: 1150 ident: bib25 article-title: Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells publication-title: Int J Oncol – volume: 31 start-page: 193 year: 2020 end-page: 204 ident: bib13 article-title: Soya-cerebroside inhibits VEGF-facilitated angiogenesis in endothelial progenitor cells publication-title: Food Agric Immunol – year: 2004 ident: bib16 publication-title: Cruciferous vegetables, isothiocyanates and indoles – volume: 437 start-page: 1 year: 2018 end-page: 12 ident: bib17 article-title: Allyl isothiocyanate, a potent chemopreventive agent targets AhR/Nrf2 signaling pathway in chemically induced mammary carcinogenesis publication-title: Mol Cell Biochem – volume: 156 start-page: 645 year: 2017 end-page: 649 ident: bib3 article-title: Global incidence and risk factors of oral cancer publication-title: Harefuah – volume: 118 start-page: 1554 year: 2012 end-page: 1565 ident: bib23 article-title: Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers publication-title: Cancer – ident: bib2 article-title: Ministry of Health and Welfare, taiwan – volume: 106 start-page: 27 year: 2016 end-page: 36 ident: bib5 article-title: Cisplatin resistance and opportunities for precision medicine publication-title: Pharmacol Res – volume: 69 start-page: 702 year: 2017 end-page: 722 ident: bib10 article-title: E-Cadherin/beta-Catenin complex: a target for anticancer and antimetastasis plants/plant-derived compounds publication-title: Nutr Canc – volume: 30 start-page: 1033 year: 2019 end-page: 1045 ident: bib12 article-title: Glucocerebroside reduces endothelial progenitor cell-induced angiogenesis publication-title: Food Agric Immunol – volume: 52 start-page: 537 year: 2019 end-page: 544 ident: bib11 article-title: Plumbagin suppresses endothelial progenitor cell-related angiogenesis in vitro and in vivo publication-title: J Funct Foods – volume: 16 start-page: 6323 year: 2018 end-page: 6330 ident: bib26 article-title: Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process publication-title: Oncol Lett – volume: 46 start-page: 733 year: 2013 ident: 10.1016/j.jfma.2020.06.025_bib38 article-title: Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials publication-title: Acc Chem Res doi: 10.1021/ar300020b – volume: 54 start-page: 1585 year: 2010 ident: 10.1016/j.jfma.2020.06.025_bib32 article-title: Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.201000005 – volume: 5 start-page: 2516 year: 2015 ident: 10.1016/j.jfma.2020.06.025_bib40 article-title: Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo publication-title: Am J Cancer Res – volume: 6 start-page: 963 year: 1953 ident: 10.1016/j.jfma.2020.06.025_bib24 article-title: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin publication-title: Cancer doi: 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q – volume: 52 start-page: 537 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib11 article-title: Plumbagin suppresses endothelial progenitor cell-related angiogenesis in vitro and in vivo publication-title: J Funct Foods doi: 10.1016/j.jff.2018.11.040 – volume: 43 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib14 article-title: Casticin inhibits human prostate cancer DU 145 cell migration and invasion via Ras/Akt/NF-kappaB signaling pathways publication-title: J Food Biochem doi: 10.1111/jfbc.12902 – volume: 7 start-page: 31 year: 2017 ident: 10.1016/j.jfma.2020.06.025_bib29 article-title: YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells publication-title: Biomedicine doi: 10.1051/bmdcn/2017070205 – volume: 54 start-page: 127 year: 2010 ident: 10.1016/j.jfma.2020.06.025_bib15 article-title: Allyl isothiocyanate as a cancer chemopreventive phytochemical publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200900323 – volume: 771 start-page: 29 year: 2015 ident: 10.1016/j.jfma.2020.06.025_bib20 article-title: Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil) publication-title: Mutat Res doi: 10.1016/j.mrfmmm.2014.11.004 – volume: 10 start-page: 1956 year: 2004 ident: 10.1016/j.jfma.2020.06.025_bib22 article-title: Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy publication-title: Clin Canc Res doi: 10.1158/1078-0432.CCR-03-1077 – volume: 15 start-page: 8756 year: 2018 ident: 10.1016/j.jfma.2020.06.025_bib19 article-title: Effect of allyl isothiocyanate on the viability and apoptosis of the human cervical cancer HeLa cell line in vitro publication-title: Oncol Lett – volume: 6 start-page: 5237 year: 2015 ident: 10.1016/j.jfma.2020.06.025_bib21 article-title: Allyl isothiocyanate induces replication-associated DNA damage response in NSCLC cells and sensitizes to ionizing radiation publication-title: Oncotarget doi: 10.18632/oncotarget.3026 – volume: 18 start-page: 1 year: 1992 ident: 10.1016/j.jfma.2020.06.025_bib8 article-title: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence publication-title: Nutr Canc doi: 10.1080/01635589209514201 – volume: 106 start-page: 27 year: 2016 ident: 10.1016/j.jfma.2020.06.025_bib5 article-title: Cisplatin resistance and opportunities for precision medicine publication-title: Pharmacol Res doi: 10.1016/j.phrs.2016.01.001 – volume: 30 start-page: 1033 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib12 article-title: Glucocerebroside reduces endothelial progenitor cell-induced angiogenesis publication-title: Food Agric Immunol doi: 10.1080/09540105.2019.1660623 – volume: 90 start-page: 305 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib33 article-title: Glucosinolates: molecular structure, breakdown, genetic, bioavailability, properties and healthy and adverse effects publication-title: Adv Food Nutr Res doi: 10.1016/bs.afnr.2019.02.008 – volume: 11 start-page: 949 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib35 article-title: PI3K-AKT-mTOR and NFkappaB pathways in ovarian cancer: implications for targeted therapeutics publication-title: Cancers doi: 10.3390/cancers11070949 – volume: 6 start-page: 1 year: 2008 ident: 10.1016/j.jfma.2020.06.025_bib7 article-title: Cisplatin: a review of toxicities and therapeutic applications publication-title: Vet Comp Oncol doi: 10.1111/j.1476-5829.2007.00142.x – volume: 43 start-page: 1141 year: 2013 ident: 10.1016/j.jfma.2020.06.025_bib25 article-title: Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells publication-title: Int J Oncol doi: 10.3892/ijo.2013.2050 – volume: 24 start-page: 20 year: 2011 ident: 10.1016/j.jfma.2020.06.025_bib30 article-title: Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways publication-title: Chem Res Toxicol doi: 10.1021/tx100248s – volume: 69 start-page: 702 year: 2017 ident: 10.1016/j.jfma.2020.06.025_bib10 article-title: E-Cadherin/beta-Catenin complex: a target for anticancer and antimetastasis plants/plant-derived compounds publication-title: Nutr Canc doi: 10.1080/01635581.2017.1320415 – volume: 54 start-page: 967 year: 2010 ident: 10.1016/j.jfma.2020.06.025_bib31 article-title: Chrysophanol induces necrosis through the production of ROS and alteration of ATP levels in J5 human liver cancer cells publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200900265 – year: 2004 ident: 10.1016/j.jfma.2020.06.025_bib16 – volume: 99 start-page: 143 year: 2020 ident: 10.1016/j.jfma.2020.06.025_bib1 article-title: Incidence trends of lip, oral cavity, and pharyngeal cancers. Global burden of disease 1990-2017 publication-title: J Dent Res doi: 10.1177/0022034519894963 – volume: 740 start-page: 364 year: 2014 ident: 10.1016/j.jfma.2020.06.025_bib6 article-title: Cisplatin in cancer therapy: molecular mechanisms of action publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2014.07.025 – volume: 31 start-page: 193 year: 2020 ident: 10.1016/j.jfma.2020.06.025_bib13 article-title: Soya-cerebroside inhibits VEGF-facilitated angiogenesis in endothelial progenitor cells publication-title: Food Agric Immunol doi: 10.1080/09540105.2020.1713055 – year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib34 article-title: Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy publication-title: Semin Canc Biol doi: 10.1016/j.semcancer.2019.12.008 – volume: 231 start-page: 421 year: 2006 ident: 10.1016/j.jfma.2020.06.025_bib18 article-title: Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells publication-title: Exp Biol Med doi: 10.1177/153537020623100408 – volume: 16 start-page: 6323 year: 2018 ident: 10.1016/j.jfma.2020.06.025_bib26 article-title: Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process publication-title: Oncol Lett – volume: 41 start-page: 1431 year: 2012 ident: 10.1016/j.jfma.2020.06.025_bib27 article-title: Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells publication-title: Int J Oncol doi: 10.3892/ijo.2012.1579 – volume: 20 start-page: 755 year: 2019 ident: 10.1016/j.jfma.2020.06.025_bib36 article-title: mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy publication-title: Int J Mol Sci doi: 10.3390/ijms20030755 – volume: 156 start-page: 645 year: 2017 ident: 10.1016/j.jfma.2020.06.025_bib3 article-title: Global incidence and risk factors of oral cancer publication-title: Harefuah – volume: 118 start-page: 1554 year: 2012 ident: 10.1016/j.jfma.2020.06.025_bib23 article-title: Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers publication-title: Cancer doi: 10.1002/cncr.26446 – volume: 437 start-page: 1 year: 2018 ident: 10.1016/j.jfma.2020.06.025_bib17 article-title: Allyl isothiocyanate, a potent chemopreventive agent targets AhR/Nrf2 signaling pathway in chemically induced mammary carcinogenesis publication-title: Mol Cell Biochem doi: 10.1007/s11010-017-3091-0 – volume: 45 start-page: 746 year: 2016 ident: 10.1016/j.jfma.2020.06.025_bib37 article-title: PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis publication-title: J Oral Pathol Med doi: 10.1111/jop.12440 – volume: 90 start-page: 200 year: 2014 ident: 10.1016/j.jfma.2020.06.025_bib39 article-title: Cancer therapeutics: targeting the apoptotic pathway publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2013.12.012 – volume: 31 start-page: 1869 year: 2012 ident: 10.1016/j.jfma.2020.06.025_bib4 article-title: Molecular mechanisms of cisplatin resistance publication-title: Oncogene doi: 10.1038/onc.2011.384 – volume: 334 start-page: 477 year: 2010 ident: 10.1016/j.jfma.2020.06.025_bib28 article-title: MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells publication-title: J Pharmacol Exp Therapeut doi: 10.1124/jpet.109.165415 – volume: 413 start-page: 122 year: 2018 ident: 10.1016/j.jfma.2020.06.025_bib9 article-title: Oxidative stress and dietary phytochemicals: role in cancer chemoprevention and treatment publication-title: Canc Lett doi: 10.1016/j.canlet.2017.11.002 |
| SSID | ssj0046996 |
| Score | 2.413195 |
| Snippet | Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned. Allyl... Background/purpose: Cisplatin-resistant oral cancer is clinically difficult to manage and the dose-dependent toxicities of cisplatin has been widely concerned.... |
| SourceID | doaj proquest pubmed crossref elsevier |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 515 |
| SubjectTerms | AITC Apoptosis CAR cells Cell Line, Tumor Cell Proliferation Cisplatin - pharmacology Cisplatin resistance Drug Resistance, Neoplasm Humans Isothiocyanates Mouth Neoplasms - drug therapy OSCC |
| SummonAdditionalLinks | – databaseName: ScienceDirect Freedom Collection 2013 dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9RAEG6WPYgX8e34ogVvEmfS6UfmqIvLIqwIurC30E_NMnTCTAaZi7_EH2tVpxPcgyt4Taq7k1SlHsnXXxHyWkOFE7zDMrWGAoWtqkLr4AvrLLK7qIqnvVXnn-TZBf94KS6PyMm0FwZhldn3jz49eet8ZJmf5rJv2-WXFUR2KbmE-SFIprqdc4VW_vbnDPOA6i_16ELhAqXzxpkR43UVEvcQWyUOT2yX_UdwShz-12LU33LQFItO75I7OYmk78brvEeOfLxPbp3n3-QPyK_P3YAoIJDJeA3aBao3m8OGtjvQTdvZg46QZtIu0jZ-b02L8GeKn_ERl0p7bOYT_GgeVEcHUm5vUUb3XT90sDLFbsY_9AFO0dTqj9p21yO2LhZQxGNiGgeKDADUom1t0_S7h-Ti9MPXk7Mit2EorCjVULjSBmalck7WteQacg4PaaazgeNPwioIxx04B8Ok5q50SF8jgmNcaGkF49Ujchy76J8QyqAGNnKthAo1r63WSlluhYccz9jSqAUpp-ff2MxRjq0yNs0ERrtqUGcN6qxBRB4TC_JmHtOPDB03Sr9Htc6SyK6dDnTbb002rybo0nNjKm205bVTxtRcM18zo1fral0uSDUZRTNtYAWXCxO1Ny4t5lHXTPyf415NdtfAu4-q0tF3-10D6dVKImE_W5DHo0HONwZpOUOag6f_ueozcpshfCd9bXpOjoft3r-A_GswL9ML9huMsi-l priority: 102 providerName: Elsevier |
| Title | Potential effects of allyl isothiocyanate on inhibiting cellular proliferation and inducing apoptotic pathway in human cisplatin-resistant oral cancer cells |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0929664620302850 https://dx.doi.org/10.1016/j.jfma.2020.06.025 https://www.ncbi.nlm.nih.gov/pubmed/32624316 https://www.proquest.com/docview/2420622902 https://doaj.org/article/fa1e4bb3abac48d7bb84a2e82ba09391 |
| Volume | 120 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QFUZ4LpTISNxTYOLaTHgFRVUhFHKjUmzV-iVQrJ-pmhfbCL-mP7YyTrMqB9sI1Gec1E_ub5JtvGHsHmOHE4ClNbTBBEcuqAIihcN6RuktdyVxbdfpdn5zJb-fq_EarL-KEjfLA44P7GKEM0toKLDjZ-NraRoIIjbCAyXiuWxe45s3J1DgHY86XO3Mtj4jcoaWeymVGZtdFzIpDYpmVO6lJ9o0lKSv3_7Uy_Qt55hXo-DF7NEFH_mm85H12L6Qn7MHp9HP8Kbv60Q3E_UGbiaXBu8hhtdqueLtGj7Sd20JCcMm7xNv0q7UtkZ45fbwnNirvqYVPDGNQcEgerfzGkQ30XT90eGZOPYx_wxZ38dzgj7t23ROjLhWYuhMcTQOnun_uKKIu8-HXz9jZ8defX06KqflC4VRZD4UvXRRO197rptESEGkEBJfeRUm_BquovPQ4JVihQfrSk2iNil5IBdopIavnbC91KbxkXGDma_VRrerYyMYB1LWTTgVEdtaVtl6wcn7-xk3K5NQgY2VmCtqFIZ8Z8pkhHp5QC_Z-N6YfdTlutf5Mbt1ZkqZ23oCRZqZIM3dF2oJVc1CYuWwVJ1o8UHvrqdVu1ARqRrBy57i3c9wZfOPJVZBCt1kbBFVLTTL9YsFejAG5uzEE44LEDV79jxt-zR4KYvDkD04HbG-43IQ3CMEGe8juf_hTHuZ37hpunjHH |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgEXxJvlaSRuKOzGcZzsESqqBboVEq3Um-VnSbVKot2sqr30l_BjmXGciB4oEtfs2N5kxvNIPn9DyDsFFY53FsvUEgoUNssSpbxLjDXI7lJkPJytWh6LxSn_epaf7ZGD4SwMwiqj7-99evDW8co0Ps1pW1XTHzOI7EJwAfNDkMS6_RaH7YttDD5cjTgPKP9Cky6UTlA8npzpQV4XPpAPsVkg8cR-2X9Ep0Dify1I_S0JDcHo8D65F7NI-rH_ow_InqsfktvL-J38Efn1vekQBgQyEbBBG0_VarVb0WoDyqkas1M15Jm0qWlV_6x0hfhniu_xEZhKW-zm411vH1TVFqTs1qCMapu2a2Bliu2ML9UOfqKh1x811aZFcF2dQBWPmWndUaQAoAaNax2m3zwmp4efTw4WSezDkJg8LbrEpsYzIwprRVkKriDpcJBnWuM5fiXMfG65Be-gmVDcphb5a3JvGc-VMDnj2ROyXze1e0YogyJYi3mRF77kpVGqKAw3uYMkT5tUFxOSDs9fmkhSjr0yVnJAo11I1JlEnUmE5LF8Qt6PY9qeouNG6U-o1lES6bXDhWZ9LqN9Sa9Sx7XOlFaGl7bQuuSKuZJpNZtn83RCssEo5HCCFXwuTFTduHQ-jrpm4_8c93awOwmbH1WlatdsNxLyq5lAxn42IU97gxxvDPJyhjwHz_9z1TfkzuJkeSSPvhx_e0HuMsTyhFdPL8l-t966V5CMdfp12Gy_AbomMsE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potential+effects+of+allyl+isothiocyanate+on+inhibiting+cellular+proliferation+and+inducing+apoptotic+pathway+in+human+cisplatin-resistant+oral+cancer+cells&rft.jtitle=Journal+of+the+Formosan+Medical+Association&rft.au=Chang%2C+Pei-Ying&rft.au=Tsai%2C+Fuu-Jen&rft.au=Bau%2C+Da-Tian&rft.au=Hsu%2C+Yuan-Man&rft.date=2021-01-01&rft.issn=0929-6646&rft.volume=120&rft.issue=1+Pt+2&rft.spage=515&rft_id=info:doi/10.1016%2Fj.jfma.2020.06.025&rft_id=info%3Apmid%2F32624316&rft.externalDocID=32624316 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-6646&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-6646&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-6646&client=summon |